The same day the U.S. Drug Enforcement Administration announces it is easing restrictions on medical research involving cannabidiol (CBD), a key component in marijuana, NYU Langone Medical Center researchers report a clinical trial suggests a pill containing CBD may reduce seizures for children and young adults with epilepsy.